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Abstract
PURPOSE: To determine whether (1) black and white women with endometrial cancer were treated by
different surgical specialties and in different types of hospitals and (2) differences in specialty and hospital
type contributed to racial differences in survival.
METHODS: Retrospective cohort study of 12,307 women aged 65 years and older who underwent surgical
treatment of endometrial cancer between 1991 and 1999 in the 11 Surveillance Epidemiology and End
Results registries.
RESULTS: Black women were more likely to have a gynecologic oncologist to perform their surgery and to be
treated at hospitals that were higher volume, larger, teaching, National Cancer Institute centers, urban, and
where a greater proportion of the surgeries were performed by a gynecologic oncologist. In unadjusted
models, black women were over twice as likely as white women who died because of cancer (hazards ratio
[HR]: 2.33), but nearly all of the initial racial difference in survival was explained by differences in cancer
stage, and grade as well as age and comorbidities at presentation (adjusted HR: 1.10). Surgical specialty was
not associated with survival and, of the hospital characteristics studied, only surgical volume was associated
with survival (P < 0.005). Adjusting for hospital characteristics did not change the racial difference in survival
(HR: 1.10). Adjustment for the specific hospital where the woman was treated eliminated the association
between race and surgeon specialty and slightly widened the residual racial difference in survival (HR: 1.23 vs.
1.10).
CONCLUSIONS: In contrast to several studies suggesting that blacks with breast cancer, colon cancer, or
cardiovascular disease are treated in hospitals with lower quality indicators, black women diagnosed with
endometrial cancer in Surveillance Epidemiology and End Results regions between 1991 and 1999 were more
likely to be treated by physicians with advanced training and in high volume, large, urban, teaching hospitals.
However, except for a modest association with hospital surgical volume, these provider and hospital
characteristics were largely unrelated to survival for women with endometrial cancer. The great majority of the
difference in survival was explained by differences in tumor and clinical characteristics at presentation.
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Abstract
Purpose—To determine if (1) black and white women with endometrial cancer were treated by
different surgical specialties and in different types of hospitals; and (2) differences in specialty and
hospital type contributed to racial differences in survival.
Methods—Retrospective cohort study of 12,307 women 65 and older who underwent surgical
treatment of endometrial cancer between 1991 and 1999 in the 11 SEER registries
Results—Black women were more likely to have a gynecologic oncologist perform their surgery
and to be treated at hospitals that were higher volume, larger, teaching, NCI centers, urban and
where a greater proportion of the surgeries were performed by a gynecologic oncologist. In
unadjusted models, black women were over twice as likely as white women to die from their
cancer (HR 2.33), but nearly all of the initial racial difference in survival was explained by
differences in cancer stage, and grade as well as age and comorbidities at presentation (adjusted
HR 1.10). Surgical specialty was not associated with survival and, of the hospital characteristics
studied, only surgical volume was associated with survival (p <0.005). Adjusting for hospital
characteristics did not change the racial difference in survival (HR 1.10). Adjustment for the
specific hospital where the woman was treated eliminated the association between race and
surgeon specialty and slightly widened the residual racial difference in survival (HR 1.23 vs. HR
1.10).
Conclusions—In contrast to several studies suggesting that blacks with breast cancer, colon
cancer or cardiovascular disease are treated in hospitals with lower quality indicators, black
women diagnosed with endometrial cancer in SEER regions between 1991–1999 were more likely
to be treated by physicians with advanced training and in high volume, large, urban, teaching
hospitals. However, except for a modest association with hospital surgical volume, these provider
and hospital characteristics were largely unrelated to survival for women with endometrial cancer.
The great majority of the difference in survival was explained by differences in tumor and clinical
characteristics at presentation.
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INTRODUCTION
Reducing racial disparities in cancer treatment and outcomes is a major focus of national
cancer organizations.1–3 Although differential treatment of patients from different racial
groups by the same provider is well known to contribute to racial disparities in health and
health care, 3, 4 recent evidence suggests that patients of different racial groups may also be
treated by different providers and in different hospitals in the US.5–8 Furthermore, these
providers may have different characteristics including their propensity to deliver certain
treatments and ability to achieve certain outcomes. Recognizing and addressing differences
in the quality of the providers and hospitals where minority patients are treated has become a
growing focus in health disparities research.
The majority of the evidence about differences in the characteristics of providers and
hospitals that treat minority patients demonstrates that black patients are more likely to be
treated by lower volume providers, with less advanced training and worse outcomes.5–8
Primary care providers who treat a greater proportion of black patients are less likely to be
board certified and more likely to report difficulty accessing resources than providers who
treat a greater proportion of white patients.7 Black patients with acute coronary events are
cared for in different hospitals with higher mortality rates than white patients with acute
coronary events and black patients.8 Similar patterns have been found for complex surgery,
where black patients are clustered within lower volume hospitals with higher mortality rates.
More recently this work has been extended to cancer care with studies demonstrating that
breast and colon cancer patients who are black are more likely to undergo surgery in low
volume hospitals with higher mortality rates,9 and that breast cancer patients who are black
are also more likely to undergo surgery in hospitals with lower rates of receipt of radiation
after breast conserving therapy.10
However, it is possible that this pattern may vary across clinical conditions and geographic
areas. One of the first studies to examine racial differences in the site of care demonstrated
that black patients with a large study of inpatient admissions for congestive heart failure,
acute myocardial infarction, pneumonia or stroke found that blacks were more likely than
whites to be admitted to a teaching hospital with better outcomes.11 Furthermore, this
difference in the site of care masked racial differences in outcomes within hospitals, so that
in the overall population there was no racial difference in quality of care or mortality.11 In
many areas of the US, racial residential segregation results in blacks being clustered within
urban neighborhoods, which are often in relatively close proximity to major urban teaching
hospitals.12 These teaching hospitals often have higher volumes and better outcomes for
many procedures than community hospitals.13 Understanding variation in the pattern of
minority patients and provider quality is important, both to ensure that efforts to reduce
disparities address the correct targets and to identify situations where the clustering of
minority patients within hospitals with better outcomes may actually be masking larger
disparities in outcomes within those hospitals.
Given this background, the goal of this study was to determine whether black and white
women with endometrial cancer are treated by different surgical specialties and in different
types of hospitals and whether differences in specialty and hospital type contribute to racial
differences in survival. We focused on endometrial cancer because of the substantial racial
disparity in endometrial cancer case fatality,14 the high rate of surgical treatment among
incident cases,15 the demonstrated relationship between surgical specialty (i.e. gynecologic
oncologist) and outcome in other gynecologic cancers,16–19 and the relative paucity of
evidence about the causes of racial disparities in this condition.
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METHODS
We conducted a cohort study of black and white women with incident endometrial cancer
diagnosed between January 1, 1991 and December 31, 1999 who underwent surgical
treatment (i.e. hysterectomy). The study data were derived from Surveillance Epidemiology
and End Results (SEER) Medicare linked files. These files link information from the SEER
national cancer registry, which included 11 sites and approximately 11% of the US
population for the study period (1991–1999), to Medicare claims for all individuals 65 years
and older with a cancer diagnosis. The SEER sites with a significant proportion of African-
Americans tend to be urban areas so that there are differences between the urban/rural
distribution of racial groups in the sample and the US population. According to the 2000 US
Census, 10% of US blacks lived in rural areas compared to 4% in the study sample and 25%
of US whites lived in rural areas compared to 34% in the study sample.20
The study cohort included all women who (1) were not diagnosed at autopsy; (2) had been
enrolled in Medicare Part A and Part B for at least 6 months at the time of diagnosis; (3) had
not been enrolled in an HMO in the 6 months prior to or following the date of diagnosis; (4)
were either black or white; and (5) underwent surgical treatment of their tumor. From the
20,012 women with incident endometrial cancer in the SEER-Medicare data between 1991–
1999, 14,562 met the first four criteria and 12,307 underwent surgical treatment. (See
Appendix for selection of study cohort). 11,286 women could be linked to a surgical
specialty, 11,789 could be linked to hospital characteristics and 10,561 had both sets of
information. For analyses of hospital characteristics, we further restricted the cohort to
women who were treated in a hospital with at least five observations in the study cohort
(N=10,073) in order to increase the stability of the estimates. These women did not differ
from the overall cohort in race, age, marital status or probability of undergoing surgery by a
gynecologic oncologist but were more likely to be stage 3 or 4 (p <0.001).
To identify the surgical providers for the study cohort, we searched the claims files for CPT
and ICD-9 codes for relevant surgical procedures for the time period from 30 days prior to
diagnosis to 90 days after diagnosis. Surgical procedures included hysterectomy (CPT codes
58180, 56308), hysterectomy and node sampling (CPT codes 56311, 58200), or
hysterectomy and extensive resection (CPT codes 58210, 58240, 58285). Surgeon specialty
was determined by linking UPIN numbers from the surgical procedure (n=19,486) to the
AMA masterfile. To identify the treating hospitals, the hospital ID numbers from the
inpatient admission for the relevant surgical procedures (n=587) were linked to AHA
information about each hospital. The hospital characteristics of interest were selected based
upon the existing literature and a priori hypotheses. These included size, urban vs. rural
location, academic affiliation, NCI Cancer Center status and receipt of Disproportionate
Share payments from Medicare. Disproportionate Share payments are based upon the
proportion of Medicare inpatient days attributable to recipients of Supplemental Security
Income and the proportion of all hospital days with Medicaid as the primary payor.
Both disease specific and overall mortality were examined. Women were categorized as
dying from their cancer if the death certificate cause of death was gynecological cancer. Of
the 5,575 women who died, 1,547 did not have death certificate information; separate
analyses were conducted excluding these women and categorizing them as dying from other
causes. Because the results of these analyses were very similar, we present the disease
specific mortality models excluding women without death certificate information.
Sociodemographic characteristics and tumor characteristics (stage, grade and histology)
were obtained from SEER data. Stage was coded according to modified AJCC staging (I, II,
III and IV). Grade was categorized as 1, 2, and 3/4. Histologic types were grouped into four
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categories according to their aggressiveness: adenocarcinoma, endometriod, papillary +/−
serous and sarcoma/other. Comorbidities were determined by reviewing inpatient and
outpatient claims during the 90 days and 2 years prior to diagnosis for a prespecified list of
conditions. This list included all comorbidities included in Elixhauser et al.21 Median
household income of the patient’s zipcode was used as a proxy for individual income.
Statistical Analysis
Characteristics of black and white women were compared using t-tests or ANOVA for
continuous variables and chi-square tests for categorical variables. Logistic regression was
used to investigate the associations between race and surgical specialty after adjusting for
covariates. Surgical specialty was initially categorized as: gynecologist only, gynecologic
oncologist only, general surgeon only, gynecologist and gynecologic oncologist,
gynecologist and general surgeon, gynecologic oncologist and general surgeon, and other.
Based upon the initial results across these categories, subsequent models combined these
categories into the presence or absence of a gynecologic oncologist. Independent variables
included in each model were age, marital status (married vs. unmarried), stage, grade,
histology, and comorbidities. Models were run with individual variables for all
comorbidities, with a summary variable for the presence of any comorbidity vs. no
comorbidities, as well as with the 90 day comorbidity measures and the 2 year comorbidity
measures and among the cohort 65 years and older and the cohort 66 years and older.
Because the results of all of these models were essentially the same and the concern for right
censoring creating bias in comorbidity assessment and for loss of observations by excluding
women under 66 years of age, we present the models with the summary comorbidity
variable from the 90 day measures for the cohort of women 65 years and older. Subsequent
models also assessed the impact of adjusting for zip code median household income (<
$25,000, $25,000–$50,000, >$50,000). Missing categories were included in the analysis as
dummy variables. Interaction terms were tested for each variable with race using a
bonferroni cutpoint of 0.05 for inclusion in the final model.
Hospital characteristics were compared between racial groups and specialist categories
(gynecologic oncologist vs. no gynecologic oncologist) using chi-square tests. Hospital case
volume was calculated as the number of cases per hospital in the data and was divided into
quartiles for analysis. The proportion of endometrial cancer surgeries performed by a
gynecologic oncologist at each hospital was calculated and analyzed as a continuous
measure and in quartiles. Additional hospital characteristics that were associated with either
patient race or surgeon specialty included medical school affiliation, bed size (<300 vs 300–
599 vs. ≥600), NCI Cancer Center status, and receipt of Disproportionate Share payments.
The contribution of the hospital where the patient was treated to the association between
race and surgeon specialty was assessed by examining the effect on the race coefficient of
adjusting for hospital characteristics or of including hospital fixed effects in the models. 392
hospitals (2,377 patients) were excluded from the fixed effect model because of lack of
variation in the outcome within the hospital.
The contributions of racial differences in surgeon specialty and hospitals to racial
differences in survival were examined using Cox proportional hazards models adjusting for
hospital characteristics and surgeon specialty or including hospital fixed effects. To
determine if hospital or provider characteristics had differential effects by patient race,
interaction terms for race and each characteristic were tested using likelihood ratio statistics.
All models using hospital characteristics adjusted for clustering of patients within hospital.
Final models were checked by examining generalized residuals.
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RESULTS
The characteristics of the study cohort are reported in Table 1. Compared to white women,
black women were more likely to be diagnosed at an advanced stage, to have higher grade
tumors and unfavorable histology. In addition, black women were slightly younger at the
time of diagnosis, lived in zip codes with lower household income, and were less likely to be
married. Types of surgical treatment differed between black and white women with black
women more likely to have undergone extensive resection and less likely to have undergone
simple hysterectomy than white women.
Surgeon specialty differed by race with black women being more likely than white women
to have a gynecologic oncologist and less likely to have a general gynecologist perform their
surgery. A significant proportion of women (16.3%) had two types of specialist involved in
their surgery, and this proportion was higher for white women (16.7%) than black women
(9.1%). Black women remained significantly more likely to have a gynecologic oncologist
perform their surgery after adjusting for sociodemographic characteristics, tumor
characteristics and comorbidities (Table 2).
Black women were more likely to die from their cancer than white women (median survival
4.7 years for black women vs. 6.4 years for white women). At the end of follow up, 31.2%
of black women had died from their cancer compared to 16.3% of white women (HR 2.33,
95% CI 1.97–2.77). The racial difference in survival was largely explained by differences in
clinical and sociodemographic characteristics. Adjustment for age, tumor characteristics and
comorbidities substantially reduced the racial difference in survival (HR 1.22, 95% 1.03–
1.45), and further adjustment for marital status and zip code derived mean household income
essentially eliminated the disparity in survival (HR 1.10, 95% 0.91–1.32). (Table 3) Surgeon
specialty was not associated with survival and adjustment for surgeon specialty did not
change the racial disparity in survival.
To examine the contribution of hospital characteristics, the sample was limited to the
subgroup of patients with hospital information and who were treated in hospitals with more
than 5 patients in the sample (N=10,073). The pattern of associations between race and
surgical specialty and race and survival in this sample did not differ from the overall sample.
For example, the unadjusted HR for black race and mortality was 2.35 (95% CI 1.93–2.86)
and the HR adjusted for patient clinical and sociodemographic characteristics was 1.16 (95%
CI 0.97–1.39).
Both patient race and surgical specialty were associated with the characteristics of the
hospital where the surgery was performed. (Table 4) Black women were more likely to be
treated at hospitals with medical school affiliations, higher volume of endometrial cancer
cases, larger numbers of beds, urban location, NCI Cancer Center status and receipt of
Disproportionate Share payments. These hospital characteristics were also associated with a
greater likelihood of having a gynecologic oncologist as the surgeon. Adjusting for these
hospital characteristics, substantially reduced the association between patient race and
surgeon specialty. (Table 2) Adjustment for the proportion of endometrial cancer surgeries
performed by a gynecologic oncologist at the hospital eliminated the association between
patient race and surgeon specialty as did inclusion of a hospital fixed effects (OR 1.09, 95%
CI 0.81–1.46).
Survival differed substantially across hospitals (p<0.0001) and was associated with surgical
volume but not with hospital teaching status, receipt of Disproportionate Share payments,
rural vs. urban location, NCI cancer center status or the proportion of the surgeries
performed by a gynecologic oncologist (Table 4). Adjustment for hospital characteristics did
not change the association between race and survival but inclusion of a hospital indicator
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variable led to a small increase in the residual racial difference in survival after adjusting for
patient characteristics (Model 2, HR 1.23, 95% CI 0.95–1.59). None of the interaction terms
for patient race and provider and hospital characteristics were statistically significant (p-
values for all interaction terms >0.05).
DISCUSSION
Understanding differences in quality of care between blacks and whites in the US is a
national priority. Endometrial cancer is an important target for these efforts as the racial
difference in endometrial cancer case fatality is larger than any other cancer in the US. This
study demonstrates that the characteristics of surgeons and hospitals differ between black
and white women undergoing surgery for endometrial cancer, but that these differences lead
to black women being more likely to be treated by the more specialized provider and in the
larger, teaching hospital than white women. However, surgeon specialty and the observable
hospital characteristics (teaching status, case volume, bed size, NCI status, receipt of
Disproportionate Share payments, percent of surgeries performed by a gynecologic
oncologist) have relatively little correlation with patient survival, so that adjusting for these
characteristic has little impact on the racial difference in survival.
Differences in provider characteristics by patient race have been described in multiple
clinical settings but the complexity of these patterns is only beginning to be
understood. 7–12, 22 In the current study, we found differences in both the types of surgeons
and the types of hospitals between black and white women who underwent surgery for
endometrial cancer in these 11 SEER sites in the 1990s. In contrast to the patterns seen for
primary care providers over that same period, black women were more likely to be treated
by the more specialized provider than were white women. However, these differences
appear to be driven by the hospital where the patient was treated rather than by racial
differences in surgical specialty within hospital. Black patients were more likely to be
treated in hospitals that had higher case volume and were larger, affiliated with medical
schools, urban and NCI centers- characteristics that were also associated with undergoing
surgery by a gynecologist oncologist. These findings are similar to the results of the study
by Kahn et al. and may reflect the overlapping geographic distributions of blacks and of
large, urban, teaching hospitals within certain areas of the US.11
Despite the strong relationship between patient race and provider characteristics, these
associations had little effect on the racial disparity in survival. Unlike studies that have
demonstrated a relationship between surgical specialty and outcomes in ovarian
cancer16, 17, 19, surgical specialty was not associated with differences in outcomes for
endometrial cancer in our data; thus, the preferential use of a gynecologic oncologist by
black women did not influence the size of the racial disparity in survival. Similarly, except
for case volume, the observable hospital characteristics in our data were not associated with
survival and adjusting for these characteristics did not influence the size of the racial
disparity in survival- as was seen with a recent analysis of racial disparities in prostate
cancer mortality. 23 However, adjusting for the specific hospital where the patient was
treated (hospital fixed effects) increased the size of the racial disparity in survival slightly
with a change in the race coefficient greater than the 15% often used as a threshold for
confounding.17
While the primary focus of this study was on racial differences in the providers and
hospitals, the study also confirms prior studies demonstrating that the vast majority of the
racial difference in endometrial cancer survival is explained by differences in cancer stage
and grade at presentation, as well as patient age and cormorbidities.15, 24, 25 The reasons for
the marked racial differences in stage and grade are unknown but may relate to racial
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differences in the use of hormone replacement therapy (as use of hormone replacement
therapy is associated with early stage, low grade cancer) as well as racial differences in
access to primary or gynecological care for timely evaluation of symptoms such as vaginal
bleeding that may be the first sign of endometrial cancer. Furthermore, while not the focus
of this analysis, we have previously demonstrated that African American women were
substantially less likely to undergo hysterectomy, the recommended treatment for all women
with endometrial cancer.15 Thus, any attention that is paid to the role of differences in
providers in either ameliorating or exacerbating disparities needs to be in context of the
importance of these other factors as the major sources of the greater mortality among black
women with endometrial cancer.
These findings have several implications for future research. Although studies of breast
cancer, colon cancer and cardiovascular disease have found that blacks tend to be treated in
hospitals with lower quality indicators than whites, we found a very different pattern for
endometrial cancer. This difference highlights the growing recognition that causes of
disparities are complex and are likely to vary by clinical condition, population and
geography. While there are clearly critical national policy issues that influence disparities,
eliminating disparities in a given area will also require understanding the specific factors
underlying that disparity. Just as all health care is local, disparities are local and results from
one area should not be assumed to generalize to another. For endometrial cancer, eliminating
the racial disparity in survival will requires understanding the factors that lead to differences
in tumor characteristics at presentation and rates of surgery and then implementing strategies
to address these factors.
This study has several limitations. We could not assess racial differences in surgeons and
hospitals amongst women who did not undergo surgery for endometrial cancer. Thus, the
study sample represents a selected subsample of the overall population of women with
endometrial cancer. While this focus on treated/hospitalized patients is common to studies of
racial differences in provider characteristics, it does not take into account any of the
selection processes that lead to treatment- some of which may vary across providers or
patient racial/ethnic group. For example, if gynecologic oncologists are more likely to
operate on black patients than are general gynecologists, the racial difference in surgeon
specialty seen in the current analyses may reflect, in part, differences in how providers select
patients for surgery rather than which providers are seen by different patients. We were able
to account for some differences in disease severity, comorbidity and sociodemographic
characteristics but it is possible that unmeasured differences in severity may contribute to
black women being seen at different hospitals than white women in our sample. Missing
data restricted the numbers of patients included in some analyses (e.g. disease specific
mortality). However, results of secondary analyses including the full sample (e.g. all cause
mortality) supported the robustness of the findings. Similarly, hospitals with small numbers
of patients were unable to be included in the hospital fixed effects models, but the results of
these models did not differ from those including the percent of surgeries done by a
gynecologic oncologist as a hospital level variable.
The sample included only the geographic area included in the SEER registry. While this
includes 11 states, it is not a random sample of the US population and differs in the
distribution of racial groups across urban and rural areas as noted previously. Thus, the
results of this analysis are not generalizable to areas of the country not represented in the
SEER data, including the rural South, which encompasses a significant proportion of elderly
Black women in the US. Importantly, because we focused this analysis on the 1990s
corresponding to prior studies of racial differences in primary care and cardiac care
providers, it is not clear the degree to which these patterns persist in 2010. Census data
suggest that the level of racial residential segregation geographic distribution of races in the
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SEER areas did not change substantially between 200 and 2010 but it is possible that other
forces have influenced racial differences in providers for endometrial cancer.26
In summary, this study suggests that black women with endometrial cancer are more likely
to be treated by surgeons with more advanced training, largely because they are more likely
to go to hospitals where these surgeons are more prevalent. Racial differences in treating
hospitals favor black women, so that adjusting for the specific treating hospital leads to a
greater disparity in survival between black and white women. However, observable hospital
characteristics such as teaching status, case volume, and surgeon specialty explain very little
of these hospital level differences in survival.
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Table 1
Characteristics of women 65 and older who underwent surgical treatment of endometrial cancer between 1991
and 1999 in the 11 SEER registries
Black White p-value
N=527 N=11,780
Mean age at diagnosis (range) 73.9 74.7 0.001
Married (%) 25.1 46.5 <0.001
Mean annual household income (%)
   <$25,000 62.4 16.7 <0.001
   $25,000–$50,000 33.8 60.4
   >$50,000 3.6 20.9
   Unknown 0.2 2.0
Stage (%)
   I 57.7 74.8 <0.001
   II 10.8 7.7
   III 13.3 7.7
   IV 13.3 6.4
   Unknown 4.9 3.4
Grade (%)
   1 16.1 33.5 <0.001
   2 24.1 35.0
   3/4 38.5 23.3
   Unknown 21.3 8.2
Histology (%)
   Adenocarcinoma 35.7 58.4 <0.001
   Endometriod 22.6 25.9
   Papillary +/−serous 23.7 9.5
   Unknown 18.0 6.2
Type of surgery (%)
   Supracervical hysterectomy 0.8 0.2 <0.001
   Total abdominal hysterectomy (TAH) 40.2 53.8
   TAH + node sampling 28.7 25.4
   TAH + extensive resection 30.4 20.6
Surgeon specialty (%)
   Gynecologic oncologist only 38.2 15.6 <0.001
   Gynecologist only 42.5 56.5
   General surgeon only 2.5 5.6
   Gynecologic oncologist + gynecologist 12.2 14.0
   Gynecologic oncologist + general surgeon 0.7 0.4
   Gynecologist +general surgeon 3.4 6.7
   Other 0.5 1.2
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